WALTHAM, Mass.--(BUSINESS WIRE)--
NeuroMetrix, Inc. (Nasdaq: NURO), reported today that it has engaged
CorProminence, LLC for investor relations services. CorProminence is a
New York-based investor relations and strategic advisory firm with a
business focus on small to mid-size companies. Its mandate with
NeuroMetrix is to plan and coordinate investor outreach in order to
expand awareness of the company and to convey significant developments
to the investment community.
"With the launch success of our Quell® device for chronic
pain and growing momentum, we want to ensure that our investor base is
engaged," said Shai N. Gozani, M.D., Ph.D., President and Chief
Executive Officer. "CorProminence has the combination of expertise in
our sector and connections in the investor community that will help us
toward our investor outreach goals."
"We are joining NeuroMetrix at an exciting juncture in its business
history," commented Scott Gordon, President of CorProminence. "We are
pleased to be working with NeuroMetrix and look forward to supporting
their success in the marketplace and the investment community."
About Quell Wearable Pain Relief Device
Quell is an
easy-to-use, over-the-counter device for relief of chronic pain. This
wearable device utilizes NeuroMetrix's wearable intensive nerve
stimulation (WINS) technology to provide pain relief. In a recent
clinical study, Quell improved chronic pain and overall health in 81% of
participants. Quell is currently available through select healthcare
professionals, retailers and online at www.QuellRelief.com.
About CorProminence, LLC
Headquartered outside Manhattan in
Garden City, New York, CorProminence, LLC is comprised of senior market
and practice leaders with expertise in institutional and retail investor
relations and integrated corporate communications. CorProminence
provides proprietary integrated investor and public relations solutions
that yield targeted exposure for small to mid-sized companies. For more
information, please visit www.corprominence.com.
About NeuroMetrix
NeuroMetrix is an innovative health-care
company that develops wearable medical technology and point-of-care
tests that help patients and physicians better manage chronic pain,
nerve diseases, and sleep disorders. The company is located in Waltham,
Massachusetts and was founded as a spinoff from the Harvard-MIT Division
of Health Sciences and Technology in 1996. For more information, please
visit www.NeuroMetrix.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151001005279/en/
NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and
Chief Financial Officer
neurometrix.ir@neurometrix.com
Source: NeuroMetrix, Inc.
News Provided by Acquire Media
